Key Financial Data Of Reporting Company

Noile-Immune Biotech Inc. - Filing #7338555

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
2023-01-01 to
2023-03-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-339,567,000 JPY
-1,127,594,000 JPY
-493,787,000 JPY
Profit (loss)
-340,177,000 JPY
-1,130,014,000 JPY
-494,395,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
4,047,254,000 JPY
4,045,977,000 JPY
2,787,552,000 JPY
Total number of issued shares
43,301,765 xbrli:shares
43,276,765 xbrli:shares
39,579,865 xbrli:shares
Net assets
5,349,775,000 JPY
5,687,452,000 JPY
3,806,221,000 JPY
Total assets
5,456,992,000 JPY
5,778,946,000 JPY
4,008,290,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-7.86
-27.25
-12.49
Diluted earnings per share
Equity-to-asset ratio
0.979 xbrli:pure
0.983 xbrli:pure
0.948 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.